Others

Rpg Life Sciences Ltd. - Outcome of Board Meeting

| Updated on April 29, 2019 Published on April 29, 2019

In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held today i.e. April 29, 2019, inter alia, considered and approved the following:

1. Audited financial results of the Company for the quarter and year ended March 31, 2019.

2. Recommended an equity dividend of Rs. 2.40 per share of Rs. 8/- each (30%) for the financial year ended March 31, 2019, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting.

3. Based on the recommendations of the Nomination and Remuneration Committee, the Board of Directors have proposed re-appointment of the following Independent Directors for a second term of 5 (five) consecutive years from September 25, 2019 to September 24, 2024, subject to approval of shareholders at the ensuing Annual General Meeting of the Company:

Sr. No Name of Director
1 Dr. Lalit Kanodia (DIN:00008050)
2 Mr. Narendra Ambwani (DIN:00236658)
3 Mr. Mahesh Gupta (DIN:00046810)
4 Mr. Manoj Maheshwari (DIN:00012341)




Profiles of the Independent Directors are attached herewith as Annexure A. It may be noted that none of the Directors are related to any other director or Key Managerial Personnel of the Company.

We further wish to inform that in terms of Circular No. NSE/CML/2018/02 dated June 20, 2018 issued by National Stock Exchange of India Limited, and Circular No. LIST/COMP/14/2018-19 dated June 20, 2018 issued by BSE Limited, the above five appointees have not been debarred from holding the office of a Director by virtue of any order by SEBI or any other authority.

The meeting commenced at 3:30 p.m. and concluded at 7.00 p.m

Pdf Link: Rpg Life Sciences Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on April 29, 2019
This article is closed for comments.
Please Email the Editor